Echo Therapeutics Inc fka ECTE

[seeker_of_value]

Thanks for your reply. All biotechs have this problem that they must constantly raise cash to fund operations. How has ECTE managed to raise cash in this period you have been invested in? Did they take benefit of higher stock prices in the intermediate period to raise cash? Have they periodically raised cash from the market by selling stock at below market prices? What caused this latest serious erosion in prices? The company seems worth much more than current prices. I would say they should be in at least the $2 range. $45M market cap seems really low for their achievement so far.